SCHEMBL20723400

SCHEMBL20723400

CC1(C)O[C@H]2[C@H](n3ccc4c(Cl)ncnc43)O[C@H](C(O)C3=COCO3)[C@@]2(C)O1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 20/20 0.42
▸ WDR77 Q9BQA1 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20721618 0.84 PRMT5 (0.59) PRMT5WDR77
SCHEMBL20721619 0.84 PRMT5 (0.59) PRMT5WDR77
SCHEMBL29391623 0.83 PRMT5 (0.47) PRMT5WDR77
SCHEMBL20721608 0.83 PRMT5 (0.47) PRMT5WDR77
SCHEMBL20721610 0.83 PRMT5 (0.47) PRMT5WDR77
SCHEMBL20721487 0.81 PRMT5 (0.61) PRMT5WDR77
SCHEMBL29391757 0.81 PRMT5 (0.61) PRMT5WDR77
SCHEMBL20721491 0.81 PRMT5 (0.61) PRMT5WDR77
SCHEMBL20723397 0.80 PRMT5 (0.41) PRMT5WDR77
SCHEMBL20721498 0.80 PRMT5 (0.63) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3952874-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 Prelude Therapeutics, Incorporated (US) 2022-02-16 — — EP disclosed
WO-2020206289-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 PRELUDE THERAPEUTICS, INCORPORATED (US) 2020-10-08 — — WO disclosed
EP-3665179-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Prelude Therapeutics, Incorporated (US) 2020-06-17 — — EP disclosed
WO-2019032859-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) PRELUDE THERAPEUTICS, INCORPORATED (US) 2019-02-14 — — WO disclosed
Send feedback